Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes. WASHINGTON, Nov. 17, 2020 /PRNewswire/ — Seven...read more
Latest news and articles
DNASTAR Integrates Genomenon Mastermind Database for Human Variant Analysis
November 17, 2020, Madison, WI DNASTAR® announced today the integration of the Mastermind database from Genomenon into the Lasergene Genomics software with the release of Lasergene® 17.2. With this integration...read more
Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA
— Ten Additional Technology Leaders Join Founding Members to Together Advance Industry Roadmap, Set Stage for Widespread Adoption of New Long-term Storage Option — — Announcement at Flash Memory...read more
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations Cambridge, United Kingdom – 9 November 2020 – Congenica, the...read more
Strata Oncology Announces Medicare Coverage of StrataNGS Comprehensive Genomic Profiling Test for Patients with Advanced Solid Tumors
Optimized for Small Tissue Samples, StrataNGS Expands Access to Precision Cancer Care Ann Arbor, Mich. October 27, 2020 — Strata Oncology, Inc., a precision oncology company advancing molecular indications for...read more
Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend
The biggest names in food, cosmetics, personal care & ‘agritech’ are looking to Eagle Genomics’ AI-augmented, knowledge discovery platform to distil robust scientific evidence in support of...read more
Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics
SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) — Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high...read more
New Report – Analytics of the Microbiome Landscape
Palo Alto, CA, October 19, 2020 – The “Analytics of the Microbiome Landscape” report has been added to the enlightenbio LLC offering. This new report provides insights into the transformational microbiome...read more
PierianDx and Pillar Biosciences Announce Partnership to Support Precision Cancer Care
Multiple targeted assays from Pillar Biosciences to be combined with the PierianDx platform to reduce time, cost, and complexity of clinical genomic testing St. LOUIS, MO. and NATICK, MA., OCTOBER 14, 2020 —PierianDx...read more
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
— World-class germline and somatic testing, liquid biopsy and tissue genomic profiling, now delivered from a single platform with unrivaled breadth and flexibility — SAN FRANCISCO, Oct. 5, 2020 /PRNewswire/...read more
